A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. Year to date metric has recorded a gain of 111.06%.However, over the last six months, we can see a weaker performance of 124.60%. Over the last 30 days, the price of XGN has fallen by 48.41%. And in the last five days, it has surged by 52.73%.
The market performance of Exagen Inc’s stock has been harmonious in recent times. Over the last year, the company’s stock reached its highest point at $3.71 on 11/20/24, while the lowest value for the same duration was $1.30 on 04/16/24.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
52-week price history of XGN Stock
Examining the 52-week high and low prices can provide valuable insights into a stock’s current status and future performance. Exagen Inc’s current trading price is 13.21% away from its 52-week high, while its distance from the 52-week low is 223.00%. The stock’s price range during this time has been between $1.30 and $3.71. The trading volume for the Healthcare sector company’s shares reached about 0.77 million for the day, which was higher than the average daily volume of 29810.0 over the last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Exagen Inc (XGN) has experienced a quarterly rise of 37.70% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 74.08M and boasts a workforce of 179 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.68, with a change in price of +2.39. Similarly, Exagen Inc recorded 51,876 in trading volume during the last 100 days, posting a change of +132.04%.
XGN’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for XGN stands at 1.83. Similarly, the long-term debt-to-equity ratio is also 1.69.
XGN Stock Stochastic Average
Today’s raw stochastic average for Exagen Inc over the last 50 days is 98.38%.This indicates a increase from the raw stochastic average of the past 20 days, which was 98.38%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 94.26% and 88.02%, respectively.
